Advertisement
Entire Site
Articles/Fact Sheets
Ask the Experts
Conference Coverage
HIV/AIDS Basics & Prevention
HIV/AIDS Basics & Prevention
Basics & Prevention: Home
HIV/AIDS Basics
HIV Prevention
HIV Testing
Who Gets HIV/AIDS?
Myths About HIV/AIDS
More ...
Just Diagnosed
Just Diagnosed
Just Diagnosed: Home
Choosing a Physician
Coping
HIV Hotlines & Orgs
Telling Others
More ...
HIV Treatment
HIV Treatment
HIV Treatment: Home
Drug Resistance
HIV Medications
Side Effects & Health Problems
Starting Treatment
Women & Pregnancy
More ...
Living With HIV
Living With HIV
Living With HIV: Home
Arts & Entertainment
Beyond Medications
Inspiring Stories
Mental Health
More ...
AIDS Policy & Activism
AIDS Policy & Activism
HIV Policy & Activism: Home
Activist Central
Medicine Recycling
U.S.-Specific News
Developing World News
More ...
HIV Around the World
HIV Around the World
HIV Around the World: Home
Africa
Asia
Latin America
U.S. and Canada
Western Europe
More ...
Conference Coverage
Conference Coverage
Conference Coverage: Home
CROI 2009
ICAAC/IDSA 2008
Previous Conferences
Upcoming Conferences
More ...
E-Mail
Glossary
Share
Combivir (AZT/3TC)
The Basics
|
News
|
Research
See also:
Medication Side Effects
|
Drug Interactions
|
All HIV Medications
Show Archived (Historical) Articles
Brand Name:
Combivir
Generic Name:
Zidovudine and lamivudine, AZT and 3TC
Adult Single Dose:
One tablet containing 300 mg AZT and 150 mg 3TC (twice a day)
Food & Liquid Restrictions:
None
Drug Class:
NRTI
The Basics
An Overview of Combivir (AZT/3TC)
(Regularly Updated)
To read PDF,
click here
From
U.S. National Institutes of Health
Combivir (Zidovudine + Lamivudine)
(August 22, 2009)
To read PDF,
click here
From
AIDS InfoNet
Combivir
(March/April 2009)
To read PDF,
click here
In
Positively Aware
, from
Test Positive Aware Network
Combivir (AZT + Epivir)
(September 28, 2007)
Basic information on dosing schedules and side effects.
From U.S. Department of Veterans Affairs
Patient Information About Combivir (AZT/3TC) (PDF)
(March 2007)
From GlaxoSmithKline
Combivir (AZT/3TC)
(October 19, 2006)
From AIDS Treatment Data Network
News
Ziagen Pills Found in Fake Combivir Packaging
(March 29, 2007)
To read PDF,
click here
From GlaxoSmithKline
Research
Switching From Zidovudine/Lamivudine to Tenofovir/Emtricitabine: Results of an Uncontrolled Cohort
(November 16, 2006)
In
8th International Congress on Drug Therapy in HIV Infection
Zidovudine/Lamivudine Inferior as First-Line NRTI Backbone
(August 15, 2006)
In
XVI International AIDS Conference
Incidence of Zidovudine-Associated Anemia May Be Lower Than Initially Thought -- Particularly With Fixed-Dose Combinations
(July 26, 2005)
In
The 3rd International AIDS Society Conference on HIV Pathogenesis and Treatment
E-Mail
Glossary
Share
Advertisement